We focused on a T-cell bispecific antibody generated to bring Folate Receptor 1 (FOLR1) expressing tumor cells in close proximity to CD3 expressing cytotoxic T-cells (Figure 1—figure supplement 1A; Geiger et al., 2020). Here, FOLR1 is linked to neoplasm.